Bioanalytical Method Development

Event Information

Registration

Online Registration is open!
Register Now!

Conference Brochure

Download Brochure
Event Details Inside

Send To A Friend

Invite a colleague to join you at this event
Send to Friend

Related Events

Find another IIR Event

Event Search Form by Industry

Advanced Search

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200
------------------------------------
Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Add Event To Calendar

Save the event dates in your Outlook calendar
Add to Outlook Diary

Resources

Resources

BioAnalytical Method Development: TwitterBioAnalytical Method Development: LinkedInBioAnalytical Method Development: labrootsBioAnalytical Method Development: ResearchGATE

Future of BioPharma Blog
  • Biorepositories: An Interview with Tracie DeHart, Dow Agrosciences
    Tracie DeHart, Dow Agrosciences, a speaker at this year's 2010 Biorepositories Conference, recently sat down with Courtney Leonard, the Biorepositories Conference Director to discuss some of the current trends in the biosciences industry.. They dis...
  • Biologics lead to tricky regulation ground
    The Lawyers Weekly looks at the legal problems that will arise as a result of the pathway that is now built from biosimilars. There is anticipated legal battles that legal battles will rage due to lack of regulation in the industry. Currently, bios...
  • Sanofi Aventis receives no from Genzyme for first offer
    Forbes shares that the first attempt for Sanofi Aventis, a bid of $18.5 billion, was rejected by Genzyme. Genzyme believes that the company should be valued at a much higher price. The bid from Sanofi Aventis has been expected. Genzyme is facing a...
  • Combination product approved for some hypertension patients
    A combination product for hypertention was recently approved by the FDA. Tribenzor, the three-in-one product, uses other hypertention drugs olmesartan medoxomil, hydrochlorothiazide, and amlodipine to relax blood vessels and allows blood to flow more...
  • Vaccines could extend cancer patients lives
    Therapeutic vaccines are one way to extent cancer patients lives. The Seattle Times recently looked at the vaccines that are in development to the patients own immune systems to fight the cancer within the body. The vaccines train white blood cells...
  • J&J receives FDA warning letter for unapproved med device products
    CNN Money reports that the FDA has set Johnson and Johnson a warning letter for selling joint products have have yet to be approved. By selling these products, they are violating the Federal Food, Drug and Cosmetic Act. Upon receiving information f...
  • Rare disease patients seek treatment
    In a recent article at Time Magazine, they ponder whether or not it is time for Pharma companies to begin treatment for rare diseases. For the most part, many go unresearched due to the small numbers of people affected, which often leaves too few pe...
  • Thermo Fisher Scientific Inc. expands biorepository in Maryland
    According to Boston.com, Thermo Fisher Scientific Inc. will be expanding their facility in Frederick, Maryland by 22,000 square feet. The extra space will be used to host cancer specimens. The majority of samples hosted at the facility are from cli...
  • Dr. Bill Maisel to direct Center of Devices and Radiological Health
    According to MedCity News, Dr. Bill Maisel has been selected to function as the deputy director of science for the Center of Devices and Radiological Health (CDRH) and chair the Center Science Council (CSC). The latter will be responsible for issuin...
  • Biosimilars: To develop as a generics or new products?
    In a recent article written by Thomas Gryta at the Dow Jones Newswire, he looks at the current situations for large Pharma when developing biosimilars: treat them as generics or new products? While there is now a pathway to have biosimilars approved...

Download 2008 Presentations
BioAnalytical Method Development: PK Assay Strategies for BiotherapeuticsPK Assay Strategies for Biotherapeutics
Alyssa Morimoto, PhD, Scientist, BioAnalytical Research and Development
Genentech
BioAnalytical Method Development: Quantitative Evaluation of Effects of FucoseDepletion on FcγRIIIA Binding and ADCC Activities of A Humanized IgG1 AntibodyQuantitative Evaluation of Effects of FucoseDepletion on FcγRIIIA Binding and ADCC Activities of A Humanized IgG1 Antibody
Shan Chung, Ph.D.
Genentech, Inc.

In The News
Loading...

Home    Register    Brochure    Send to a Colleague
© 2009 IIR USA, LTD. All Rights Reserved.